UK markets closed

TherapeuticsMD, Inc. (TXMD)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
3.0100-0.0700 (-2.27%)
At close: 04:00PM EDT
3.1200 +0.11 (+3.65%)
After hours: 07:50PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Sep 2023)Next qtr. (Dec 2023)Current year (2023)Next year (2024)
No. of analysts1111
Avg. Estimate-0.05-0.02-0.380.35
Low estimate-0.05-0.02-0.380.35
High estimate-0.05-0.02-0.380.35
Year ago EPS-3.138.2311.96-0.38
Revenue estimateCurrent qtr. (Sep 2023)Next qtr. (Dec 2023)Current year (2023)Next year (2024)
No. of analysts1111
Avg. Estimate500k600k2M9M
Low estimate500k600k2M9M
High estimate500k600k2M9M
Year ago sales20.92M1.15M69.96M2M
Sales growth (year/est)-97.60%-47.90%-97.10%350.00%
Earnings history29/09/202230/12/202230/03/202329/06/2023
Est. EPS-0.57-1.110.06-0.07
Actual EPS-3.138.23-0.37-0.24
Difference-2.569.34-0.43-0.17
Surprise %-449.10%841.40%-716.70%-242.90%
EPS trendCurrent qtr. (Sep 2023)Next qtr. (Dec 2023)Current year (2023)Next year (2024)
Current estimate-0.05-0.02-0.380.35
7 days ago-0.05-0.02-0.380.35
30 days ago-0.05-0.02-0.380.35
60 days ago-0.05-0.02-0.380.35
90 days ago-0.05-0.02-0.380.35
EPS revisionsCurrent qtr. (Sep 2023)Next qtr. (Dec 2023)Current year (2023)Next year (2024)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesTXMDIndustrySector(s)S&P 500
Current qtr.98.40%N/AN/AN/A
Next qtr.-100.20%N/AN/AN/A
Current year-103.20%N/AN/AN/A
Next year192.10%N/AN/AN/A
Next 5 years (per annum)17.60%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A